Nu Skin Scientific Advisory Board

Lars Bohlin, Ph.D.
Professor of Pharmacognosy, University of Uppsala, Sweden

For 30 years, Dr. Bohlin has studied, researched, and taught pharmacy. He earned his M.S. and Ph.D. in pharmacy at Uppsala University in Sweden, where he currently serves as a professor on the faculty. He developed marine pharmacognosy in Sweden and his interests have focused on ethnopharmacology with an emphasis on anti-inflammatory natural products. He is widely consulted as an expert by both private and public organizations, and sits on numerous research councils. A native of Stockholm, Sweden, Dr. Bohlin has contributed on many levels— both his own community, serving as the Chairman of the Board for the Department of Pharmacy at Uppsala, and internationally. He sits on editorial or advisory boards for such scientific journals as Phytotherapy Research, Phytomedicine, J. Ethnopharmacology, and Planta Medica.

Paul Alan Cox, Ph.D.

Director of the Institute for Ethnomedicine

One of the world’s top ethnobotanists, Dr. Cox  specializes in the use of plants by indigenous cultures. During his career, he has published more than 150 scientific articles and three books. Dr. Cox received his M.Sc. in ecology at the University of Wales as a Fullbright Fellow. In 1978, Dr. Cox entered Harvard as a Danforth Fellow and National Science Foundation Fellow, and in 1981 he received his Ph.D. in biology. He was later awarded a National Science Foundation Presidential Young Investigator Award by President Ronald Reagan. Currently, Dr. Cox serves as Chairman of the Seacology Foundation, an organization he founded to assist in preserving island rain forests and cultures.

Zoe Diana Draelos, M.D., F.A.A.D.

Dermatologist and Editor-in-Chief, Journal of Cosmetic Dermatology

Dr. Draelos is a practicing, board-certified dermatologist and a Fellow of the American Academy of Dermatology with a research interest in cosmetics, toiletries and biologically active skin medications. She is a consulting professor in the Department of Dermatology at Duke University School of Medicine and has a clinical practice in High Point, N.C. She has been a visiting professor at more than 45 medical institutions nationally and internationally. She is the author of nine textbooks, including Cosmetics in Dermatology. Dr. Draelos has contributed chapters to 23 textbooks, written 300 published papers, and currently serves on eight journal editorial boards. In 2006, she received a cosmetics industry lifetime achievement award from Health Beauty America for her research contributions in topical formulations.

Makoto Kuro-o, M.D., Ph.D.
Associate Professor of Pathology, University of Texas Southwestern Medical Center

Dr. Kuro-o received an M.D. in 1985 from the University of Tokyo, Japan. He completed his residency training at Tokyo Metropolitan Geriatric Hospital in 1988, after which he returned to the University of Tokyo as a clinical fellow in cardiology until 1998. He received a Ph.D. in 1991 from the University of Tokyo, following which he pursued postdoctoral training at the National Institute of Neuroscience in Japan. During his postdoctoral work, he identified the klotho gene—an aging suppressor gene in mammals. In 1998, he became an Assistant Professor of Pathology at the University of Texas Southwestern Medical Center at Dallas. His laboratory  focuses on understanding the molecular mechanism by which the klotho protein suppresses aging.

Tomas A. Prolla, Ph.D

Co-founder, LifeGen Technologies, Professor, departments of Genetics and Medical Genetics, University of Wisconsin

Tomas A. Prolla, Ph.D., studied in the Department of Molecular Bio-physics and Biochemistry at Yale University, receiving a doctoral degree in 1994. He completed post-doctoral training at the Human and Molecular Genetics Department at Baylor College of Medicine, then joined the faculty of the Department of Genetics and Medical Genetics at the University of Wisconsin in 1997. Dr. Prolla has received several awards of scientific excellence, including the Shorb Lecturer Award, the Burroughs Wellcome Young Investigator Award, the Basil O’Connor Starter Scholar Research Award, and the Howard Hughes Medical Institute New Faculty Startup Award. Dr. Prolla’s work currently focuses on the use of gene expression profiling, lifespan studies, and histopathology. In 2001, he and Dr. Richard Weindruch founded LifeGen Technologies, LLC, a company focused on nutritional genomics, including the impact of nutrients and caloric restriction on the aging process. Dr. Prolla has published several articles in prestigious scientific journals such as Science.

Molly Wanner, M.D., M.B.A

Dermatologist, Massachusetts General Hospital and Harvard Medical School

Dr. Wanner is a board certified dermatologist who specializes in laser and cosmetic dermatology at Massachusetts General Hospital and Harvard Medical School. She is currently conducting clinical and basic science research in the area of cosmetic and laser dermatology. Her research interests include topical cosmetic products, fat and cellulite, and laser and cosmetic devices. Dr. Wanner has presented nationally and authored multiple articles in such publications as Dermatologic Surgery, Lasers in Surgery and Medicine, and Journal of the American Academy of Dermatology. She serves on task forces for the American Academy of Dermatology, the American Society of Dermatologic Surgery, and the Women’s Dermatologic Society. Wanner graduated Magna Cum Laude from Amherst College. Dr. Wanner attended Columbia University where she graduated Alpha Omega Alpha from the medical school and Beta Gamma Sigma from the business school.